The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.
Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but ...
Such herd immunity effects have been demonstrated following the introduction of meningococcal serogroup C conjugate (MCC) vaccines, with reductions in disease attack rates in unimmunized ...
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
MenACWY-CRM was supplied in 2 vials: 1 vial of lyophilized powder containing 10 μg of MenA oligosaccharide conjugated to CRM 197 and a second liquid conjugate vaccine component containing 5 μg ...
Robert F. Kennedy Jr. has been Health and Human Services secretary for all of a week, but he’s already pressing what looks like an anti-vaccine agenda. Mr. Kennedy never did disavow his vaccine ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
Vaccine helps protect against the A, B, C, W, and Y serogroups of Neisseria meningitidis. (HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A ...
Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood.
Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research in cell biology uses microscopic and molecular tools ...
Sickle cell anemia, also called drepanocytosis, is a blood disorder or hemoglobin disorder that changes the shape of red blood cells. The abnormally shaped red blood cells interfere with the delivery ...
Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...